We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+1.57%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$4.19B
AUM Growth
-$112M
Cap. Flow
-$143M
Cap. Flow %
-3.43%
Top 10 Hldgs %
14.46%
Holding
608
New
27
Increased
203
Reduced
268
Closed
35

Top Buys

Rank Stock Value
1
TECH icon
Bio-Techne
TECH
+$24.8M
2
CMCSA icon
Comcast
CMCSA
+$23.2M
3
ADI icon
Analog Devices
ADI
+$21.6M
4
PARA
Paramount Global Class B
PARA
+$16.3M
5
EL icon
Estee Lauder
EL
+$14.3M

Top Sells

Rank Stock Value
1
ANSS
Ansys
ANSS
+$29.6M
2
VIAB
Viacom Inc. Class B
VIAB
+$27.4M
3
AMZN icon
Amazon
AMZN
+$23.7M
4
EMN icon
Eastman Chemical
EMN
+$22.9M
5
BA icon
Boeing
BA
+$21.8M

Sector Composition

Rank Sector Weight
1 Healthcare 17.22%
2 Industrials 14.56%
3 Consumer Discretionary 11.53%
4 Technology 10.55%
5 Financials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADP icon
501
Automatic Data Processing
ADP
$109B
$323K 0.01%
4,759
-190
-4% -$12.9K
VT icon
502
Vanguard Total World Stock ETF
VT
$75.3B
$322K 0.01%
5,400
WFM
503
DELISTED
Whole Foods Market Inc
WFM
$322K 0.01%
6,352
-546
-8% -$29.1K
MDLZ icon
504
Mondelez International
MDLZ
$83.4B
$317K 0.01%
9,164
-2,360
-20% -$80.7K
SE
505
DELISTED
Spectra Energy Corp Wi
SE
$316K 0.01%
8,551
-99
-1% -$3.59K
TXN icon
506
Texas Instruments
TXN
$248B
$315K 0.01%
6,684
FTI icon
507
TechnipFMC
FTI
$28.6B
$314K 0.01%
8,064
VOD icon
508
Vodafone
VOD
$37.1B
$312K 0.01%
8,486
-6,724
-44% -$259K
MWIV
509
DELISTED
MWI VETERINARY SUPPLY, INC.
MWIV
$311K 0.01%
2,000
DOC icon
510
Healthpeak Properties
DOC
$15.5B
$310K 0.01%
8,764
-1,098
-11% -$37.9K
GSK icon
511
GSK
GSK
$107B
$309K 0.01%
4,628
-560
-11% -$37.9K
F icon
512
Ford
F
$60.9B
$306K 0.01%
19,615
-3,176
-14% -$49.1K
NOV icon
513
NOV
NOV
$6.84B
$306K 0.01%
4,352
-921
-17% -$63.2K
IDXX icon
514
Idexx Laboratories
IDXX
$44.9B
$304K 0.01%
5,000
COL
515
DELISTED
Rockwell Collins
COL
$301K 0.01%
3,775
-50
-1% -$3.93K
EEP
516
DELISTED
Enbridge Energy Partners
EEP
$298K 0.01%
10,880
+2,000
+23% +$55.9K
VNQ icon
517
Vanguard Real Estate ETF
VNQ
$39.9B
$293K 0.01%
4,154
-16,325
-80% -$1.12M
CLX icon
518
Clorox
CLX
$12B
$291K 0.01%
3,310
-775
-19% -$68K
NLY icon
519
Annaly Capital Management
NLY
$17.3B
$290K 0.01%
6,613
-40
-0.6% -$1.73K
RTN
520
DELISTED
Raytheon Company
RTN
$287K 0.01%
2,909
JPS
521
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$286K 0.01%
33,000
KEY icon
522
KeyCorp
KEY
$23.8B
$285K 0.01%
20,000
IBB icon
523
iShares Biotechnology ETF
IBB
$9.45B
$284K 0.01%
3,606
+510
+16% +$42.5K
STT icon
524
State Street
STT
$48.4B
$282K 0.01%
4,050
GLW icon
525
Corning
GLW
$107B
$279K 0.01%
13,400
-800
-6% -$15K

Similar funds

Segall Bryant & Hamill's Q1 2014 Portfolio in Review

As of Q1 2014, Segall Bryant & Hamill held 608 positions worth $4.19B, down 2.6% from $4.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Segall Bryant & Hamill withdrew a net $143M in Q1 2014, closing 35 positions and reducing 268 holdings. Its most notable exit was Wabtec, an estimated $5.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Segall Bryant & Hamill opened a new position in Estee Lauder worth $13.8M.

  • Segall Bryant & Hamill's largest Q1 2014 buy was Estee Lauder: 205,607 shares worth $13.8M.
  • Segall Bryant & Hamill added most to Bio-Techne in Q1 2014, an estimated $24.8M increase.
  • Segall Bryant & Hamill's biggest Q1 2014 reduction was Ansys, cutting an estimated $29.6M.
  • Segall Bryant & Hamill fully exited Wabtec in Q1 2014, selling an estimated $5.1M.
  • Segall Bryant & Hamill's ten largest holdings make up 14% of its $4.19B portfolio in Q1 2014.
  • Segall Bryant & Hamill opened 27 new positions and closed 35 in Q1 2014.
  • Segall Bryant & Hamill's portfolio value fell 2.6% quarter-over-quarter to $4.19B.

Based on Segall Bryant & Hamill's 13F filing for Q1 2014, filed 14 May 2014.